SONNET BIOTHERAPEUTC HLDNG I's ticker is and the CUSIP is 83548R204. A total of 1 filers reported holding SONNET BIOTHERAPEUTC HLDNG I in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $490 | – | 1,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ayrton Capital LLC | 765,425 | $275,553 | 0.99% |
| SABBY MANAGEMENT, LLC | 1,215,534 | $437,592 | 0.38% |
| Anson Funds Management LP | 3,520,000 | $1,267,200 | 0.10% |
| CVI Holdings, LLC | 701,634 | $252,588 | 0.10% |
| Walleye Capital LLC | 1,664,595 | $599,254 | 0.01% |
| Alyeska Investment Group, L.P. | 848,000 | $305,280 | 0.00% |
| Alyeska Investment Group, L.P. | 951,806 | $342,650 | 0.00% |
| BOOTHBAY FUND MANAGEMENT, LLC | 136,231 | $49,043 | 0.00% |
| IFP Advisors, Inc | 142 | $244 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 2 | $1 | 0.00% |